Cargando…
Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft Model()()
Glioblastoma (GBM), the most common primary brain tumor found in adults, is extremely aggressive. These high-grade gliomas, which are very diffuse, highly vascular, and invasive, undergo unregulated vascular angiogenesis. Despite available treatments, the median survival for patients is dismal. ELTD...
Autores principales: | Zalles, Michelle, Smith, Nataliya, Saunders, Debra, Saran, Tanvi, Thomas, Lincy, Gulej, Rafal, Lerner, Megan, Fung, Kar-Ming, Chung, Junho, Hwang, Kyusang, Jin, Junyeong, Battiste, James, Towner, Rheal A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7090355/ https://www.ncbi.nlm.nih.gov/pubmed/32208341 http://dx.doi.org/10.1016/j.tranon.2019.12.009 |
Ejemplares similares
-
Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model
por: Zalles, Michelle, et al.
Publicado: (2019) -
ELTD1 as a multi-focal target for malignant gliomas: preclinical studies
por: Zalles, Michelle, et al.
Publicado: (2021) -
A tale of two multi‐focal therapies for glioblastoma: An antibody targeting ELTD1 and nitrone‐based OKN‐007
por: Zalles, Michelle, et al.
Publicado: (2021) -
OKlahoma Nitrone-007: novel treatment for diffuse intrinsic pontine glioma
por: Thomas, Lincy, et al.
Publicado: (2020) -
Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020)